There are five awards to be presented at the Gala Dinner to be held at the Doltone House on Monday 21st April 2008. The awards are:
 
Broker of the Year
This award recognises the outstanding contribution to the Biotechnology Industry by a broker. Nominees must have illustrated exceptional understanding of the industry as demonstrated through the provision of sound recommendations for investment in Biotech companies.
Nominees:
ABN Amro
BBY
Eg Capital
Lodge Partners
Taylor Collison
Wilson

CEO of the Year
This award recognises outstanding management practices within the Biotechnology industry. Nominees must have illustrated excellence and innovation in their leadership practices. Qualifiers of this award are required to have demonstrated how their leadership has created a committed, motivated and effective workforce and successful company.
Nominees:
Dr Greg Collier – Chemgenex
Mr Peter Cook - Biota
Dr Alan Robertson - Pharmaxis

Transaction of the Year
The term ‘transaction’ can be applied to partnerships, commercialisation, agreements, mergers and acquisitions that took place in 2007 (calendar year). The transaction must demonstrate innovation and show how they have/will contribute to the progression of the product/company. Qualifiers of this award will have contributed significantly to the field of biotechnology through the development of, and investment in, biotechnology which has promised potential.
Nominees:
Acrux / Organon
EvoGenix / Peptech (Arana)
Inverness Medical Innovations / Panbio
Pfizer / Psivida
Polynovo / Biomet
Starpharma / SSL International

Biotech Debut of the Year
This award recognises the successful debut of a new biotech company onto the ASX within 2007 (calendar year). Debutant companies must have demonstrated a strategic approach to listing and should have achieved either a significant company awareness in the market, or has outstanding initial results within the first 6-12 months.
Nominees:
Advanced Surgical Design & Manufacture Limited
Halcygen
Hexima Limited
ImpediMed
QRxPharma
Universal Biosensors

Legends Award
This award recognises an individual that has illustrated a longstanding contribution to the field of Biotechnology/Medical Device Industry. The individual will have demonstrated longevity in the industry, coupled with the consistent development and discovery of biotechnology products that have contributed to the development of the health and life sciences industry.
Nominees:
Dr Peter Farrell (Resmed)
Professor Ian Fraser
Dr Brian McNamee (CSL)
Dr Chris Roberts (Cochlear)